Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 2
2012 1
2013 2
2014 3
2015 1
2016 2
2017 4
2018 2
2019 3
2020 5
2021 7
2022 8
2023 2
2024 6
2025 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean m barzan (7 results)?
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
Nabet BY, Hamidi H, Lee MC, Banchereau R, Morris S, Adler L, Gayevskiy V, Elhossiny AM, Srivastava MK, Patil NS, Smith KA, Jesudason R, Chan C, Chang PS, Fernandez M, Rost S, McGinnis LM, Koeppen H, Gay CM, Minna JD, Heymach JV, Chan JM, Rudin CM, Byers LA, Liu SV, Reck M, Shames DS. Nabet BY, et al. Cancer Cell. 2024 Mar 11;42(3):429-443.e4. doi: 10.1016/j.ccell.2024.01.010. Epub 2024 Feb 15. Cancer Cell. 2024. PMID: 38366589 Free article.
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer.
Patil NS, Nabet BY, Müller S, Koeppen H, Zou W, Giltnane J, Au-Yeung A, Srivats S, Cheng JH, Takahashi C, de Almeida PE, Chitre AS, Grogan JL, Rangell L, Jayakar S, Peterson M, Hsia AW, O'Gorman WE, Ballinger M, Banchereau R, Shames DS. Patil NS, et al. Cancer Cell. 2022 Mar 14;40(3):289-300.e4. doi: 10.1016/j.ccell.2022.02.002. Epub 2022 Feb 24. Cancer Cell. 2022. PMID: 35216676 Free article.
Five-year survival in patients with extensive-stage small cell lung cancer treated with atezolizumab in the Phase III IMpower133 study and the Phase III IMbrella A extension study.
Reck M, Dziadziuszko R, Sugawara S, Kao S, Hochmair M, Huemer F, de Castro G Jr, Havel L, Bernabé Caro R, Losonczy G, Lee JS, Kowalski DM, Andric Z, Califano R, Veatch A, Gerstner G, Batus M, Morris S, Kaul M, Cuchelkar V, Li H, Danner BJ, Nabet BY, Liu SV. Reck M, et al. Lung Cancer. 2024 Oct;196:107924. doi: 10.1016/j.lungcan.2024.107924. Epub 2024 Aug 10. Lung Cancer. 2024. PMID: 39306923 Clinical Trial.
House staff-led interdisciplinary morbidity and mortality conference promotes systematic improvement.
Tignanelli CJ, Embree GGR, Barzin A. Tignanelli CJ, et al. J Surg Res. 2017 Jun 15;214:124-130. doi: 10.1016/j.jss.2017.02.065. Epub 2017 Mar 6. J Surg Res. 2017. PMID: 28624033
We present a resident-led interdisciplinary morbidity and mortality (M&M) conference utilizing postconference task forces to identify unique system issues, classify key contributors to interdisciplinary complications, and implement systems solutions. ...CONCLUSI …
We present a resident-led interdisciplinary morbidity and mortality (M&M) conference utilizing postconference task forces …
Comparison of mid-term effectiveness and safety of one-anastomosis gastric bypass and sleeve gastrectomy in patients with super obesity (BMI 50 kg/m(2)).
Tasdighi E, Mousapour P, Khalaj A, Sadeghian Y, Mahdavi M, Valizadeh M, Barzin M. Tasdighi E, et al. Surg Today. 2022 May;52(5):854-862. doi: 10.1007/s00595-021-02387-2. Epub 2021 Oct 24. Surg Today. 2022. PMID: 34689285
PURPOSES: There is no consensus regarding the optimal bariatric procedure in patients with super obesity [body mass index (BMI) 50 kg/m(2)]. This study compared the outcomes of one-anastomosis gastric bypass (OAGB) with those of sleeve gastrectomy (SG) in these patients. …
PURPOSES: There is no consensus regarding the optimal bariatric procedure in patients with super obesity [body mass index (BMI) 50 kg/m …
Remission and relapse of diabetes after sleeve gastrectomy and one-anastomosis gastric bypass: The Tehran Obesity Treatment Study.
Sadeghi S, Hosseinpanah F, Khalaj A, Ebadinejad A, Mahdavi M, Valizadeh M, Barzin M. Sadeghi S, et al. Diabetes Obes Metab. 2024 Dec;26(12):6007-6015. doi: 10.1111/dom.15974. Epub 2024 Sep 30. Diabetes Obes Metab. 2024. PMID: 39344845
METHODS: An observational prospective study with 5 years of follow-up was conducted in a total of 891 patients (82.5% female) with concomitant T2DM and obesity (body mass index 30.0 kg/m(2)) undergoing SG or OAGB between March 2013 and March 2021. T2DM remission was defi …
METHODS: An observational prospective study with 5 years of follow-up was conducted in a total of 891 patients (82.5% female) with concomita …
Body Composition Changes Following Sleeve Gastrectomy Vs. One-Anastomosis Gastric Bypass: Tehran Obesity Treatment Study (TOTS).
Barzin M, Heidari Almasi M, Mahdavi M, Khalaj A, Valizadeh M, Hosseinpanah F. Barzin M, et al. Obes Surg. 2021 Dec;31(12):5286-5294. doi: 10.1007/s11695-021-05722-1. Epub 2021 Oct 12. Obes Surg. 2021. PMID: 34637105
MATERIALS AND METHODS: A prospective study was conducted on 3864 patients with severe obesity who underwent either SG (2746, 76.1% women, mean age: 39.2 11.6 years, and BMI: 44.3 5.6 kg/m(2)) or OAGB (1118, 82.2% women, age: 39.9 10.7 years, BMI: 45.6 6.3 kg/m …
MATERIALS AND METHODS: A prospective study was conducted on 3864 patients with severe obesity who underwent either SG (2746, 76.1% women, me …
Diet quality and anthropometric indices of patients undergone bariatric surgery: the prospective Tehran obesity treatment study.
Hosseini-Esfahani F, Kazemi-Aliakbar M, Koochakpoor G, Barzin M, Khalaj A, Valizadeh M, Mirmiran P. Hosseini-Esfahani F, et al. BMC Surg. 2023 May 12;23(1):125. doi: 10.1186/s12893-023-02032-4. BMC Surg. 2023. PMID: 37173656 Free PMC article.
METHODS: A total of 160 obese patients (BMI 35 kg/m(2)) were undergone sleeve gastrectomy (SG) (n = 108) or gastric bypass (GB) (n = 52), participated in this study. ...
METHODS: A total of 160 obese patients (BMI 35 kg/m(2)) were undergone sleeve gastrectomy (SG) (n = 108) or gastric bypass (GB) (n …
Prevalence and predictors of weight recurrence following bariatric surgery: A longitudinal prospective cohort study from Tehran Obesity Treatment Study (TOTS).
Almasi MH, Barzin M, Mahdavi M, Khalaj A, Valizadeh M, Hosseinpanah F. Almasi MH, et al. Obes Res Clin Pract. 2024 Jan-Feb;18(1):43-50. doi: 10.1016/j.orcp.2024.01.001. Epub 2024 Jan 16. Obes Res Clin Pract. 2024. PMID: 38233323
RESULTS: Among 1939 participants followed up for 72 months, WR definitions were applied to 650 patients (75.4% females) with an average BMI of 44.3 5.4 kg/m(2),491 (75.5%) and 159 (24.5%) of whom underwent SG and GB, respectively. WR group had relatively higher weights a …
RESULTS: Among 1939 participants followed up for 72 months, WR definitions were applied to 650 patients (75.4% females) with an average BMI …
44 results